Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

First trimester exposure to paroxetine and risk of cardiac malformations in infants: the importance of dosage
Anick Bérard, Élodie Ramos, Évelyne Rey, et al.
Birth Defects Research (2006) Vol. 80, Iss. 1, pp. 18-27
Closed Access | Times Cited: 274

Showing 1-25 of 274 citing articles:

Use of Selective Serotonin-Reuptake Inhibitors in Pregnancy and the Risk of Birth Defects
Sura Alwan, Jennita Reefhuis, Sonja A. Rasmussen, et al.
New England Journal of Medicine (2007) Vol. 356, Iss. 26, pp. 2684-2692
Open Access | Times Cited: 495
Use of antidepressant medications during pregnancy: a multisite study
Susan E. Andrade, Marsha A. Raebel, Jeffrey S. Brown, et al.
American Journal of Obstetrics and Gynecology (2007) Vol. 198, Iss. 2, pp. 194.e1-194.e5
Closed Access | Times Cited: 400
Untreated depression during pregnancy: Short- and long-term effects in offspring. A systematic review
Salvatore Gentile
Neuroscience (2015) Vol. 342, pp. 154-166
Closed Access | Times Cited: 393
Antidepressant Use in Pregnancy and the Risk of Cardiac Defects
Krista F. Huybrechts, Kristin Palmsten, Jerry Avorn, et al.
New England Journal of Medicine (2014) Vol. 370, Iss. 25, pp. 2397-2407
Open Access | Times Cited: 359
Delivery outcome after maternal use of antidepressant drugs in pregnancy: an update using Swedish data
Margareta Reis, Bëngt Källén
Psychological Medicine (2010) Vol. 40, Iss. 10, pp. 1723-1733
Closed Access | Times Cited: 336
Selective serotonin reuptake inhibitors in pregnancy and congenital malformations: population based cohort study
Lars Henning Pedersen, Tore Henriksen, Mogens Vestergaard, et al.
BMJ (2009) Vol. 339, Iss. sep23 1, pp. b3569-b3569
Open Access | Times Cited: 296
Selected Pregnancy and Delivery Outcomes After Exposure to Antidepressant Medication
Lori E. Ross, Sophie Grigoriadis, Lana Mamisashvili, et al.
JAMA Psychiatry (2013) Vol. 70, Iss. 4, pp. 436-436
Closed Access | Times Cited: 255
Selective Serotonin Reuptake Inhibitors and Risk for Major Congenital Anomalies
Heli Malm, Miia Artama, Mika Gissler, et al.
Obstetrics and Gynecology (2011) Vol. 118, Iss. 1, pp. 111-120
Closed Access | Times Cited: 212
Paroxetine and fluoxetine in pregnancy: a prospective, multicentre, controlled, observational study
Orna Diav‐Citrin, Svetlana Shechtman, Dafna Weinbaum, et al.
British Journal of Clinical Pharmacology (2008) Vol. 66, Iss. 5, pp. 695-705
Open Access | Times Cited: 207
Prevalence of severe congenital heart disease after folic acid fortification of grain products: time trend analysis in Quebec, Canada
Raluca Ionescu‐Ittu, Ariane Marelli, Andrew S. Mackie, et al.
BMJ (2009) Vol. 338, Iss. may12 2, pp. b1673-b1673
Open Access | Times Cited: 207
Teratogenic mechanisms of medical drugs
Marleen M. H. J. van Gelder, Iris A.L.M. van Rooij, Richard K. Miller, et al.
Human Reproduction Update (2010) Vol. 16, Iss. 4, pp. 378-394
Open Access | Times Cited: 195
Evaluation of the Risk of Congenital Cardiovascular Defects Associated With Use of Paroxetine During Pregnancy
Adrienne Einarson, Alessandra Pistelli, Marco De Santis, et al.
American Journal of Psychiatry (2008) Vol. 165, Iss. 6, pp. 749-752
Closed Access | Times Cited: 189
Major congenital malformations following prenatal exposure to serotonin reuptake inhibitors and benzodiazepines using population‐based health data
Tim F. Oberlander, William Warburton, Shaila Misri, et al.
Birth Defects Research (2008) Vol. 83, Iss. 1, pp. 68-76
Open Access | Times Cited: 187
Paroxetine for the treatment of depression: a critical update
Sara Gibiino, Alessandro Serretti
Expert Opinion on Pharmacotherapy (2012) Vol. 13, Iss. 3, pp. 421-431
Closed Access | Times Cited: 177
Gender differences in antidepressant drug response
Robert Keers, Katherine J. Aitchison
International Review of Psychiatry (2010) Vol. 22, Iss. 5, pp. 485-500
Closed Access | Times Cited: 172
Modulation of Serotonin Transporter Function during Fetal Development Causes Dilated Heart Cardiomyopathy and Lifelong Behavioral Abnormalities
C.W. Noorlander, Frederique F. T. Ververs, Peter G. J. Nikkels, et al.
PLoS ONE (2008) Vol. 3, Iss. 7, pp. e2782-e2782
Open Access | Times Cited: 164
Use of antidepressants during pregnancy and the risk of spontaneous abortion
Hamid Reza Nakhai-Pour, Perrine Broy, Anick Bérard
Canadian Medical Association Journal (2010) Vol. 182, Iss. 10, pp. 1031-1037
Open Access | Times Cited: 164
Increase in use of selective serotonin reuptake inhibitors in pregnancy during the last decade, a population‐based cohort study from the Netherlands
Marian K. Bakker, P Kölling, Paul B. van den Berg, et al.
British Journal of Clinical Pharmacology (2007) Vol. 65, Iss. 4, pp. 600-606
Open Access | Times Cited: 161
Congenital Heart Disease Associated With Selective Serotonin Reuptake Inhibitor Use During Pregnancy
Christina L. Wichman, Katherine M. Moore, Tara R. Lang, et al.
Mayo Clinic Proceedings (2009) Vol. 84, Iss. 1, pp. 23-27
Open Access | Times Cited: 158
Antidepressant use in pregnancy: a critical review focused on risks and controversies
Nancy Byatt, Kristina M. Deligiannidis, Marlene P. Freeman
Acta Psychiatrica Scandinavica (2012) Vol. 127, Iss. 2, pp. 94-114
Open Access | Times Cited: 157
Monoamine-Sensitive Developmental Periods Impacting Adult Emotional and Cognitive Behaviors
Deepika Suri, Cátia M. Teixeira, Martha K. Caffrey Cagliostro, et al.
Neuropsychopharmacology (2014) Vol. 40, Iss. 1, pp. 88-112
Open Access | Times Cited: 152
National trends in antidepressant medication treatment among publicly insured pregnant women
Krista F. Huybrechts, Kristin Palmsten, Helen Mogun, et al.
General Hospital Psychiatry (2013) Vol. 35, Iss. 3, pp. 265-271
Open Access | Times Cited: 152
First trimester paroxetine use and the prevalence of congenital, specifically cardiac, defects: A meta‐analysis of epidemiological studies
Keele Wurst, Charles Poole, Sara A. Ephross, et al.
Birth Defects Research (2009) Vol. 88, Iss. 3, pp. 159-170
Closed Access | Times Cited: 150
Patterns of Antidepressant Medication Use Among Pregnant Women in a United States Population
Sura Alwan, Jennita Reefhuis, Sonja A. Rasmussen, et al.
The Journal of Clinical Pharmacology (2010) Vol. 51, Iss. 2, pp. 264-270
Closed Access | Times Cited: 149
The Use of Central Nervous System Active Drugs During Pregnancy
Bëngt Källén, Natalia Borg, Margareta Reis
Pharmaceuticals (2013) Vol. 6, Iss. 10, pp. 1221-1286
Open Access | Times Cited: 147
Page 1 - Next Page

Scroll to top